[1] 韩敬民.丙戊酸钠与托吡酯治疗初诊癫痫患者效果对比[J].国际医药卫生导报,2017,23(12):1918-1920. DOI:10.3760/cma.j.issn.1007-1245.2017.12.033.

[2]        刘玉波.抗菌药物相关性癫痫的研究进展[J].天津药学,2017,29(6):65-68. DOI:10.3969/j.issn.1006-5687. 2017. 06.021.

[3]        马辉,孙亮,王瑜歆. 药物引起的癫痫发作[C]//2013年全国医药学术交流会暨临床药学与药学服务研究进展培训班论文集,2013:325-327.

[4]        陈新谦,金有豫,汤光. 新编药物学[M]. 17版. 北京:人民卫生出版社,2011:61.

[5]      Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions[J]. Clin Pharmacol Ther, 1981, 30(2):239-245. DOI: 10.1038/clpt.1981.154.

[6]        Chow KM, Szeto CC, Hui AC, et al. Retrospective review of neurotoxicity induced by cefepime and ceftazidime[J]. Pharmacotherapy, 2003, 23(3):369-373. DOI: 10.1592/phco.23.3.369.32100.

[7]        Grill MF, Maganti R. Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring[J]. Ann Pharmacother, 2008, 42(12):1843-1850. DOI: 10.1345/aph.1L307.

[8]        肖昌钱,韩奇.头孢哌酮钠舒巴坦钠致癫痫发作[J].药物不良反应杂志,2015,17(1):55-56. DOI:10.3760/cma.j.issn.1008-5734.2015.01.012.

[9]        Sugimoto M, Uchida I, Mashimo T, et al. Evidence for the involvement of GABA(A) receptor blockade in convulsions induced by cephalosporins[J]. Neuropharmacology, 2003, 45(3):304-314. DOI: 10.1016/s0028-3908(03)00188-6.

[10]        谢芳.20例头孢唑肟不良反应分析[J].海峡药学,2012,24(4):256-257. DOI:10.3969/j.issn.1006-3765. 2012. 04.144.

[11]        黄妙婵.39例头孢唑肟钠注射剂的不良反应分析[J].国际医药卫生导报,2010,16(21):2642-2644. DOI:10.3760/cma.j.issn.1007-1245.2010.21.026.